Correlation Between Zura Bio and Design Therapeutics
Can any of the company-specific risk be diversified away by investing in both Zura Bio and Design Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zura Bio and Design Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zura Bio Limited and Design Therapeutics, you can compare the effects of market volatilities on Zura Bio and Design Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zura Bio with a short position of Design Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zura Bio and Design Therapeutics.
Diversification Opportunities for Zura Bio and Design Therapeutics
0.18 | Correlation Coefficient |
Average diversification
The 3 months correlation between Zura and Design is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Zura Bio Limited and Design Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Design Therapeutics and Zura Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zura Bio Limited are associated (or correlated) with Design Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Design Therapeutics has no effect on the direction of Zura Bio i.e., Zura Bio and Design Therapeutics go up and down completely randomly.
Pair Corralation between Zura Bio and Design Therapeutics
Given the investment horizon of 90 days Zura Bio Limited is expected to generate 2.88 times more return on investment than Design Therapeutics. However, Zura Bio is 2.88 times more volatile than Design Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Design Therapeutics is currently generating about 0.01 per unit of risk. If you would invest 816.00 in Zura Bio Limited on August 27, 2024 and sell it today you would lose (543.00) from holding Zura Bio Limited or give up 66.54% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 85.89% |
| Values | Daily Returns |
Zura Bio Limited vs. Design Therapeutics
Performance |
| Timeline |
| Zura Bio Limited |
| Design Therapeutics |
Zura Bio and Design Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Zura Bio and Design Therapeutics
The main advantage of trading using opposite Zura Bio and Design Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zura Bio position performs unexpectedly, Design Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Design Therapeutics will offset losses from the drop in Design Therapeutics' long position.| Zura Bio vs. Eliem Therapeutics | Zura Bio vs. HCW Biologics | Zura Bio vs. Scpharmaceuticals | Zura Bio vs. Milestone Pharmaceuticals |
| Design Therapeutics vs. Monte Rosa Therapeutics | Design Therapeutics vs. Werewolf Therapeutics | Design Therapeutics vs. Ikena Oncology | Design Therapeutics vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |